Artivion | CRY - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Abbott USD 6.8B 1.72B 2026-03
Accuray USD 41.29M 22.05M 2025-12
AngioDynamics USD 41.64M 14.26M 2025-09
Artivion USD 55.76M 9.14M 2026-03
AtriCure USD 146.16M 21.26M 2026-03
Baxter International USD 2.02B 51M 2026-03
Becton, Dickinson and Co. USD 813M 73M 2026-03
Boston Scientific USD 1.45B 512M 2026-03
Edwards Lifesciences USD 2.4B 538M 2026-03
Inogen USD 106.48M 2.79M 2025-09
Integra LifeSciences USD 236.81M 1.76M 2026-03
J&J USD 21.69B 1.98B 2026-03
Mesa Laboratories USD 28.98M 8.55M 2025-12
Orthofix International USD 120.28M 38.25M 2026-03
Pfizer USD 1.7B 561M 2026-03
ResMed USD 1.66B 243.44M 2026-03
Stryker USD 2.88B 1.13B 2026-03
Tandem Diabetes Care USD 179.32M 88.69M 2026-03
Teleflex USD 309.41M 69.15M 2026-03
Terumo JPY 217.16B 12.86B 2025-09
Trinity Biotech USD 5.14M 3.8M 2025-12